MySheen

China has become a leader in licorice research and development.

Published: 2024-11-05 Author: mysheen
Last Updated: 2024/11/05, A few days ago, it was learned from the founding meeting of the professional committee of traditional Chinese medicine of the World Federation of traditional Chinese Medicine and the international symposium on traditional Chinese medicine that China has successfully used chiral catalysis technology to purify the active ingredients of licorice, and increased it from 3% to 97%, greatly saving medicinal materials. At the same time, the recent advent of a new drug, chiral liver drug "Tianqing Ganmei", shows that China has occupied a leading position in the world in the research and innovation of licorice preparation. Chiral technology is through the scientific adjustment of the chemical structure of drugs.

A few days ago, it was learned from the inaugural meeting of the Professional Committee of Traditional Chinese Medicine of the World Federation of Traditional Chinese Medicine and the International Symposium on Traditional Chinese Medicine that China has successfully applied chiral catalytic technology to the purification of effective components of licorice, and increased it from 3% to 97%, greatly saving medicinal materials. At the same time, following the recent emergence of a new class of drugs, chiral liver medicine "Tianqing Ganmei", it shows that China has occupied a leading position in the world in the research and development and innovation of licorice preparations.

Chiral technology is to scientifically adjust the chemical structure of drugs, so as to eliminate ineffective or harmful ingredients in drugs, so that the effective ingredients of drugs are purer, the toxic side effects are smaller, the curative effect is faster, and the course of treatment is shorter. Liquoric root is widely distributed in China, known as "national grass", and is also a widely used raw material medicine for medicinal and edible purposes at home and abroad.

Tao Huiqi, president of Jiangsu Zhengda Tianqing Pharmaceutical, introduced that Zhengda Tianqing Pharmaceutical has devoted itself to the development and research of licorice for 20 years and has reached several domestic leaders: the first to launch "diammonium glycyrrhizinate" products that are easy to be absorbed by human body; the first to launch "magnesium isoglyrhizinate" products with extremely high purity by chiral technology; and the first to launch "diammonium glycyrrhizinate lipid complex" products that can alleviate the effect of gastric acid on drug efficacy by using phospholipid complex technology. In particular, magnesium isoglyrhizinate product "Tianqing Ganmei", which was included in the national "863" plan, is the first new drug with independent intellectual property rights in the field of anti-inflammatory and liver protection in China.

 
0